Charles Schwab Investment Management Inc. Has $54.15 Million Position in Integer Holdings Co. (NYSE:ITGR)

Charles Schwab Investment Management Inc. increased its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 1.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 408,588 shares of the medical equipment provider's stock after purchasing an additional 4,559 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.22% of Integer worth $54,146,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Loomis Sayles & Co. L P lifted its position in shares of Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock worth $69,943,000 after buying an additional 15,446 shares during the period. Jane Street Group LLC lifted its holdings in shares of Integer by 23.3% during the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock valued at $19,682,000 after acquiring an additional 28,572 shares during the period. Verition Fund Management LLC grew its holdings in shares of Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider's stock worth $451,000 after purchasing an additional 515 shares during the last quarter. Versant Capital Management Inc grew its stake in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after purchasing an additional 183 shares during the last quarter. Finally, KBC Group NV increased its holdings in shares of Integer by 83.3% in the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock valued at $212,000 after purchasing an additional 726 shares in the last quarter. Institutional investors own 99.29% of the company's stock.

Remove Ads

Analysts Set New Price Targets

A number of brokerages recently commented on ITGR. KeyCorp lifted their price objective on Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Wells Fargo & Company restated an "overweight" rating and issued a $160.00 price objective on shares of Integer in a report on Tuesday, December 3rd. Benchmark lifted their target price on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. Finally, Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, Integer has an average rating of "Moderate Buy" and a consensus target price of $149.00.

Integer Trading Up 1.2 %

NYSE:ITGR traded up $1.36 on Monday, reaching $119.25. The company's stock had a trading volume of 549,399 shares, compared to its average volume of 306,406. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36. The business's 50-day moving average price is $134.11 and its two-hundred day moving average price is $132.76. The firm has a market cap of $4.01 billion, a PE ratio of 35.49, a PEG ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Equities research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.